Caminati, M., Fassio, A., Alberici, F., Baldini, C., Bello, F., Cameli, P., et al. (2024). Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group. ALLERGY, 79(2), 516-519 [10.1111/all.15934].

Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group

Delvino, P;
2024

Lettera in rivista
benralizumab; dupilumab; EGPA; eosinophilic granulomatosis with polyangiitis; mepolizumab; monoclonal antibodies; omalizumab; reslizumab; severe asthma; T2 inflammation;
English
31-ott-2023
2024
79
2
516
519
open
Caminati, M., Fassio, A., Alberici, F., Baldini, C., Bello, F., Cameli, P., et al. (2024). Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group. ALLERGY, 79(2), 516-519 [10.1111/all.15934].
File in questo prodotto:
File Dimensione Formato  
Caminati-2024-Allergy-VoR.pdf

accesso aperto

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Creative Commons
Dimensione 474.56 kB
Formato Adobe PDF
474.56 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/467439
Citazioni
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 4
Social impact